Fasting-mimicking Diet With Chemo-immunotherapy in Non-small Cell Lung Cancer (NSCLC)

NCT03700437 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2022-05-12

No results posted yet for this study

Summary

The purpose of this study is to learn the effects of fasting on cancer cells while you get maintenance treatment.

Conditions

Interventions

OTHER

Fasting-Mimicking Diet

Chemo-immunotherapy + FMD (fast-mimicking diet)

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Shadia Jalal, MD · Indiana University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-02
Primary Completion
2022-03-23
Completion
2022-03-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03700437 on ClinicalTrials.gov